• Outstanding Seal
  • Antimicrobial properties
  • Promotes per-apical healing
  • Easy obturations and follow-up

BioRoot™ RCS. Succeed.

For more information on this exciting new product go to 


Article: Volume 44 Number 9 Page 806 - October 2017

Prev    Article P806    Next  Read article

  Dent Update 2017; 44: 806-808

Editorial:  End of the road for the randomized controlled trial in restorative dentistry?

Feedback:  0 comments, 0 ratings

Abstract: Satisfactory survival of restorations is central to good practice, not only because unfulfilled patient expectations may lead to adverse medicolegal circumstances, but also because third party funders, managers and governments may also be inquisitive as to the performance of clinicians in their pay. However, there seems to be an obsession among researchers with the Randomized Controlled Clinical Trial (RCCT), and, ok, it is the internationally recognized gold standard.

Author notes: Trevor Burke